|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
|
|
|
beta-adrenergic antagonist
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
|
|
|
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide hydrochloride
|
|
4'-(1-hydroxy-2-(isopropylamino)ethyl)methanesulfonanilide monohydrochloride
|
ChemIDplus
|
|
4-(2-Isopropylamino-1-hydroxyaethyl)methanesulfonailid hydrochlorid
|
ChemIDplus
|
|
isopropylaminohydroxyethylmethanesulfonanilide hydrochloride
|
ChemIDplus
|
|
N-(2-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}ethyl)propan-2-aminium chloride
|
IUPAC
|
|
N-isopropyl-β-(4-methanesulfonamidophenyl)ethanolamine hydrochloride
|
ChemIDplus
|
|
sotalol HCl
|
ChemIDplus
|
|
sotalol monohydrochloride
|
ChEBI
|
9(2)